[Clinical study of bortezomib in the treatment of multiple myeloma patients with renal failure].
作者信息
Cao Zhi-gang, Liu Mo, Zhou Hong-wei
出版信息
Zhonghua Xue Ye Xue Za Zhi. 2013 Jan;34(1):74-5.
PMID:23597473
Abstract
摘要
相似文献
1
[Clinical study of bortezomib in the treatment of multiple myeloma patients with renal failure].
Zhonghua Xue Ye Xue Za Zhi. 2013 Jan;34(1):74-5.
2
[Safety evaluation of bortezomib in multiple myeloma patients with severe renal failure].
Gan To Kagaku Ryoho. 2011 Feb;38(2):237-41.
3
Reversibility of renal impairment in patients with multiple myeloma treated with bortezomib-based regimens: identification of predictive factors.
Clin Lymphoma Myeloma. 2009 Aug;9(4):302-6. doi: 10.3816/CLM.2009.n.059.
4
Current therapy of myeloma induced renal failure.
Leuk Lymphoma. 2008 May;49(5):833-4. doi: 10.1080/10428190801972482.
5
Bortezomib and dexamethasone in previously untreated multiple myeloma associated with renal failure and reversal of renal failure.
Acta Haematol. 2006;116(4):255-8. doi: 10.1159/000095876.
6
Outcomes of patients with multiple myeloma and renal impairment treated with bortezomib, cyclophosphamide, and dexamethasone without plasma exchange.
Eur J Haematol. 2012 Nov;89(5):432-4. doi: 10.1111/ejh.12008. Epub 2012 Sep 13.
7
Treatment of patients with multiple myeloma complicated by renal failure with bortezomib-based regimens.
Leuk Lymphoma. 2008 May;49(5):890-5. doi: 10.1080/10428190801930506.
8
Activity and safety of bortezomib in multiple myeloma patients with advanced renal failure: a multicenter retrospective study.
Blood. 2007 Mar 15;109(6):2604-6. doi: 10.1182/blood-2006-09-046409. Epub 2006 Nov 30.
9
Bortezomib-based therapy as induction regimen of an autograft program in front-line treatment of multiple myeloma with end-stage renal disease.
Ann Hematol. 2010 Aug;89(8):821-2. doi: 10.1007/s00277-009-0867-7. Epub 2009 Dec 2.
10
[The clinical study on treatment with bortezomib for multiple myeloma].
Zhonghua Xue Ye Xue Za Zhi. 2011 Apr;32(4):265-7.
Zotero 插件